A randomized double blind, placebo-controlled trial of efficacy and safety of Kamishoyosan in patients with climacteric symptoms
Not Applicable
- Conditions
- Climacteric symptoms
- Registration Number
- JPRN-UMIN000005079
- Lead Sponsor
- Hirosaki University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with serious gastrointestinal weakness 2) Patients with anorexia, nausea and/or vomiting 3) Patients with psycho-neurologic disease (SDS>=60) 4) Patients with a history of drug allergy or hypersensitivity reaction to Kampo medicine 5) Patients with serious complications (hepatic, renal, cardiac diseases or malignancy tumor) 6) Patients who have been participated in other clinical trial within 4months before enrollment, or will participate in a clinical trial. 7) Patients who are assessed to be inappropriate for study participation by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method